Gale Arthur Granger
Affiliations: | Molecular Biology and Biochemistry | University of California, Irvine, Irvine, CA |
Area:
cellular immunology, tumor immunologyWebsite:
http://darwin.bio.uci.edu/~faculty/granger/index.htmlGoogle:
"Gale Arthur Granger"Bio:
Parents
Sign in to add mentor| Russell S Weiser | grad student | 1965 | University of Washington | |
| (Studies on in vitro homograft rejection in mice.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Badgwell BD, Valentino DJ, Jeffes EB, et al. (2003) Intra-arterial administration of TNF-alpha followed by arterial ablation is an effective therapy for a regionally confined TNF-resistant rat mammary adenocarcinoma. Cancer Immunology, Immunotherapy : Cii. 52: 10-6 |
| Jadus MR, Graf MR, Wepsic HT, et al. (1997) Development Of Systemic Immunity To Glioblastoma Multiforme Using Tumor Cells Genetically Engineered To Express The Membrane-Bound Isoform Of Macrophage-Colony Stimulating Factor Journal of Immunotherapy. 20: 419 |
| Rose GS, Tocco LM, Granger GA, et al. (1996) Development and characterization of a clinically useful animal model of epithelial ovarian cancer in the Fischer 344 rat American Journal of Obstetrics and Gynecology. 175: 593-599 |
| Santin AD, Hiserodt JC, Fruehauf J, et al. (1996) Effects of irradiation on the expression of surface antigens in human ovarian cancer. Gynecologic Oncology. 60: 468-74 |
| Katsura K, Park M, Gatanaga M, et al. (1996) Identification of the proteolytic enzyme which cleaves human p75 TNF receptor in vitro. Biochemical and Biophysical Research Communications. 222: 298-302 |
| Choi SS, Gatanaga M, Granger GA, et al. (1996) Prostaglandin-E2 regulation of tumor necrosis factor receptor release in human monocytic THP-1 cells. Cellular Immunology. 170: 178-84 |
| Santin AD, Hiserodt JC, DiSaia PJ, et al. (1996) Differential effects of high-dose gamma irradiation on the production of transforming growth factor-beta in fresh and established human ovarian cancer. Gynecologic Oncology. 61: 403-8 |
| Santin AD, Ioli GR, Hiserodt JC, et al. (1996) Development and characterization of an interleukin-2-transduced human ovarian carcinoma tumor vaccine not expressing major histocompatibility complex molecules. American Journal of Obstetrics and Gynecology. 174: 633-40 |
| Santin AD, Rose GS, Hiserodt JC, et al. (1996) Effects of cytokines combined with high-dose gamma irradiation on the expression of major histocompatibility complex molecules and intercellular adhesion molecule-1 in human ovarian cancers International Journal of Cancer. 65: 688-694 |
| Santin AD, Ioli GR, Hiserodt JC, et al. (1995) Development and in vitro characterization of a GM-CSF secreting human ovarian carcinoma tumor vaccine. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 5: 401-410 |